Servier

About Servier
Servier is a global pharmaceutical group governed by a Foundation. Servier relies on a strong geographical footprint in over 150 countries. As a world leader in cardiology, Servier’s ambition is to become a focused and innovative player in oncology by targeting hard-to-treat cancers. That is why the Group allocates over 70% of its R&D budget to developing targeted and innovative therapies in oncology.
Servier has been working for more than 30 years in Russia and is one of the leading pharmaceutical companies.
Additional information is available on www.servier.ru